Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1No longer available 1

Sponsor Class

OTHER 5NETWORK 2

Study Type

Interventional 1Expanded_access 1

Sponsor

Cancer Type

Genitourinary 2CNS 2Gynecologic 1

Conditions

Neuroblastoma 2Recurrence 1

Interventions

Radiotherapy 58Temozolomide 37Vincristine 33Cyclophosphamide 31Etoposide 25Carboplatin 25Filgrastim 23Cisplatin 22Granulocyte Colony-Stimulating Factor 18Lomustine 14Doxorubicin 13Chemotherapy, Adjuvant 13Peripheral Blood Stem Cell Transplantation 12Magnetic Resonance Spectroscopy 12Topotecan 11Radiation 11Isotretinoin 11Platinum 10sargramostim 9Specimen Handling 9Radiotherapy, Conformal 9Irinotecan 9Carmustine 91,2-diaminocyclohexaneplatinum II citrate 9etoposide phosphate 8Thiotepa 8Radiotherapy, Intensity-Modulated 8Radiosurgery 8Melphalan 8Immunohistochemistry 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Ketoconazole × CNS × Clear all
NCT02163356 2022-03-31

SPOC2013-001

South Plains Oncology Consortium

Phase 1 Terminated
4 enrolled
CNS

Neuroblastoma, Recurrence

NCT02075177 2022-03-21

Expanded Access Study of Fenretinide Lym-X-Sorb Plus Ketoconazole in Neuroblastoma

South Plains Oncology Consortium

No longer available
CNS

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡